Delivery Order SPE2DB22D3016-SPE2DB25FAWD0
Award Date 5/12/25
Potential Completion Date 6/3/25
Potential Value $19K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $41,178.10 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of GAMUNEX-C 40 gram/400 mL vials. This competitively awarded, firm fixed-price contract is non-set-aside and scheduled for completion by August 21, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. GAMUNEX-C is an immune globulin intravenous (human) product used in treating immune deficiency disorders and is a critical pharmaceutical...
- The Defense Logistics Agency awarded a $13,963.20 firm fixed price delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 40 gram/400 mL vials on June 30, 2025, with an ultimate completion date of July 22, 2025. GAMUNEX-C is an intravenous immunoglobulin (IVIG) product used to treat various immunodeficiency conditions and autoimmune disorders. This competitively awarded, non-set-aside contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $13,963.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Gamunex-C 40 gram/400 mL vials. This is a non-set-aside competitive award with an ultimate completion date of September 9, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Gamunex-C is an intravenous immunoglobulin therapy commonly used to treat immunodeficiency disorders and other immune-related...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $55,852.80 delivery order on August 18, 2025, for GAMUNEX-C 40 gram/400 ml vials with a completion date of September 9, 2025. This firm fixed price contract was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. GAMUNEX-C is an intravenous immunoglobulin (IVIG) therapy used to treat immune deficiencies and certain autoimmune and inflammatory...
- The Defense Logistics Agency awarded a $11,636.00 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of GAMUNEX-C 40 gram/400 mL vials. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 14, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. GAMUNEX-C is an intravenous immunoglobulin (IVIG) therapy used to treat various immunodeficiency and autoimmune conditions, making it a critical...
- The Defense Logistics Agency awarded a $1,831.41 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Gamunex-C 10 gram/100 mL vials. This competitively awarded, firm fixed-price contract has an ultimate completion date of September 5, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Gamunex-C is an intravenous immunoglobulin product used for treating immunodeficiency disorders and other immune-mediated conditions,...
- The Defense Logistics Agency awarded a $13,963.20 delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 40 gram/400 milliliter vials on April 21, 2025, with a completion date of May 12, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. GAMUNEX-C is an intravenous immune globulin (IVIG) product used to treat immunodeficiency and autoimmune disorders, representing a...
- The U.S. Department of Defense, through its Medical Supply Chain division, awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Gamunex-C 10 gram/100 mL vials totaling $6,104.70. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of October 10, 2025, and performance occurring at the contractor's facility in Conshohocken, Pennsylvania. Gamunex-C is an intravenous immunoglobulin (IVIG) therapy used to treat various immune...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,468.56 for GAMUNEX-C 1 gram/10 mL vials on August 26, 2025, with an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. GAMUNEX-C is an intravenous immunoglobulin used to treat primary immunodeficiency and other...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of GAMUNEX-C 40 Gram/400 mL vials, valued at $4,654.40 with a firm fixed price structure. This is an unset-aside, competitively awarded contract with an ultimate completion date of August 20, 2025, and performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. GAMUNEX-C is an intravenous immunoglobulin (IVIG) product used to treat primary...